Abstract:Trisomy 7 is the most frequently observed type of rare autosomal trisomies in genome-wide non-invasive prenatal screening (NIPS). Currently, the clinical significance of trisomy 7 NIPS-positive results is still unknown. We reviewed two independent cohorts from two laboratories where similar NIPS metrics were applied. A total of 70,441 singleton cases who underwent genome-wide NIPS were analyzed, among which 39 pregnancies were positive for trisomy 7, yielding a screen-positive rate of 0.055% (39/70,441). There… Show more
“…Several recent reviews and meta-analyses have been published on NIPS. 4,[58][59][60][61][62] Compared with traditional screening, the 2019 health technology assessment by Health Quality Ontario determined that NIPS was effective in a general or average-risk population to screen for T21, T18, and T13. 58 Our results similarly show the high performance of NIPS to screen for the common trisomies in a general population.…”
“…Several recent reviews and meta-analyses have been published on NIPS. 4,[58][59][60][61][62] Compared with traditional screening, the 2019 health technology assessment by Health Quality Ontario determined that NIPS was effective in a general or average-risk population to screen for T21, T18, and T13. 58 Our results similarly show the high performance of NIPS to screen for the common trisomies in a general population.…”
“…T7 is the most common RAT, with a rate of 0.056% among NIPS examinations, and has a mostly favourable outcome 20 . Zhu et al 20 reviewed 85 cases of T7 detected by NIPS.…”
Section: Discussionmentioning
confidence: 99%
“…T7 is the most common RAT, with a rate of 0.056% among NIPS examinations, and has a mostly favourable outcome 20 . Zhu et al 20 reviewed 85 cases of T7 detected by NIPS. Among them, 88.2% were live births with a normal outlook; 14.1% had intrauterine growth restriction, preterm birth or low birth weight; 3.5% presented with ultrasound abnormalities; and no fetal loss was observed.…”
This study was performed to assess the association between detection of rare autosomal trisomies (RATs) by non‐invasive prenatal screening (NIPS) and adverse pregnancy outcomes. We retrospectively analyzed women with high‐risk RATs results from January 2014 to December 2020. The women's clinical information was collected, and their pregnancy outcomes were compared with those of women with low‐risk results. In total, 151 (0.24%) RATs results were reported among 62,752 NIPS examinations. Sixty‐five women chose to undergo amniocentesis for confirmation, which revealed 3 cases of true fetal mosaicism for RATs and a positive predictive value of 4.6% (3/65). Among the 139 women with available outcomes, 26 (18.7%) had a preterm birth, 10 (7.2%) underwent pregnancy termination because of fetal defects and 5 (3.6%) had miscarriages. Interestingly, compared with the control group, pregnancies in which NIPS revealed trisomy 16 (T16), T22, T9 and T2 were at higher risk of adverse outcomes, including preterm birth, miscarriage and ultrasound abnormalities. However, the risk of adverse outcomes was comparable between the control group and pregnancies with positive results of T7, T3, T8 and T20. In summary, the risk of adverse pregnancy outcomes was higher in women with specific RATs‐positive NIPS results. Pregnancies with T16, T22, T9 and T2 results, even if false‐positive, should be considered high‐risk pregnancies.
“…Even though RATs are in majority of cases restricted to placenta, cases like the present one can also be among those being detected by NIPT. Their detection could help omitting increased risk of miscarriage, intrauterine growth restriction [ 23 , 24 ], low birth weight [ 25 ], small-for-gestational-age infants [ 26 ], uniparental disomy [ 22 ] and neonatal intensive care unit admission [ 27 ]. Therefore, early identification of RATs is helpful to control risks of adverse pregnancy outcomes [ 28 ].…”
Background
So called cell-free fetal DNA (cffDNA) in the maternal plasma, which is derived from placenta, is widely used to screen fetal aneuploidies, including trisomy 21, 18, 13 and sex chromosomes. Here we reported a case of trisomy 8 mosaicism (T8M), which was initially identified via cffDNA screening in noninvasive prenatal testing (NIPT).
Methods
A 35-year-old woman received cffDNA screening at 17th week of gestation. Amniocentesis was performed subsequently, and karyotyping, single-nucleotide polymorphism array (SNP-array) and BACs-on-Beads™ (BoBs™) were used to determine fetal chromosome content. Interphase fluorescence in situ hybridization (FISH) was applied to determine the copy number of chromosome 8.
Results
An enhanced risk for fetal trisomy 8 was identified by cffDNA screening in the studied pregnant woman. After amniocentesis trisomy 8 was found in 1 of 73 metaphases. SNP-array on DNA derived from cultured amniocytes and neonatal cord blood cells suggested the presence of T8M. Interphase FISH on native neonatal cord blood cells confirmed T8M with a percentage of 10%. The Bobs™ fluorescence data also suggested that 8q23-8q24 was amplified.
Conclusions
The current study shows that NIPT is suited to provide hints on rare autosomal trisomies, which have to be further validated and confirmed by other approaches.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.